Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Evidence-Based Complementary and Alternative Medicine : Ecam|October 14, 2004
Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue SyndromeXin Q Wang, Takashi Takahashi, Shi-Jie Zhu, et al.
Biological & Pharmaceutical Bulletin|January 7, 2020
Neuroinflammation, Oxidative Stress, and Neurogenesis in a Mouse Model of Chronic Fatigue Syndrome, and the Treatment with Kampo MedicineQiang He, Mio Sawada, Naruhiro Yamasaki, et al.
Neurochemical Research|March 5, 2008
Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41)Rui Chen, Junji Moriya, Jun-ichi Yamakawa, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 31, 2010
Mao-to Prolongs the Survival of and Reduces TNF-alpha Expression in Mice with Viral MyocarditisZhu Shijie, Junji Moriya, Jun'ichi Yamakawa, et al.
Plos One|October 18, 2011
In vivo tracking of transplanted mononuclear cells using manganese-enhanced magnetic resonance imaging (MEMRI)Kenichi Odaka, Ichio Aoki, Junji Moriya, et al.
Scientific Reports|November 9, 2018
Brain structural connectivity and neuroticism in healthy adultsIssei Ueda, Shingo Kakeda, Keita Watanabe, et al.
Circulation Research|November 27, 2009
Inhibition of semaphorin as a novel strategy for therapeutic angiogenesisJunji Moriya, Tohru Minamino, Kaoru Tateno, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 24, 2018
Intracranial vessel wall lesions in patients with systematic lupus erythematosusSatoru Ide, Shingo Kakeda, Mari Miyata, et al.
Psychiatry Research|March 16, 2010
Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy studyNaoki Goto, Reiji Yoshimura, Junji Moriya, et al.
Human Psychopharmacology|December 1, 2009
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophreniaNaoki Goto, Reiji Yoshimura, Shingo Kakeda, et al.
Pageof 9